The initiative aims to engage with over 3,000 hospitals and healthcare institutions nationwide over the next two to three years, leading efforts to implement effective antimicrobial stewardship programs (AMSPs)
Read More (1)_20240710200257_original_image_28.webp)
AMR poses a significant threat to public health in India, with 297,000 deaths attributed to it in 2019 and 1,042,500 associated deaths
Read More
This novel anti-infective, invented by Orchid Pharma, aims to address the rising threat of antimicrobial resistance (AMR) and has been approved for the treatment of complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP)
Read More
